Regarding the chemotherapy outcomes, one study by R.Li et al. showed the association between EXO1 rs9350 and survival of patients receiving platinum-based chemotherapy in NSCLC (37). The gene discussed is EXO1; the disease is non-small cell lung carcinoma.